Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban and Apixaban Therapy by Novel Automated Thrombelastography
Background: Direct-acting oral anticoagulants (DOACs) do not require monitoring. Measurement of DOAC effect would be useful in the event of bleeding, trauma, and thromboembolism while on anticoagulation. We evaluated the effectiveness of the investigational DOAC assays on the TEG®6s Hemostasis Analy...
Saved in:
Main Authors: | Ramin Artang, Joao Dias, Mark Walsh, Kevin P Bliden, Jørn Dalsgaard Nielsen, Maren Anderson, Brain Thurston, Udaya S. Tantry, Jan Hartmann, Paul A Gurbel |
---|---|
Format: | article |
Language: | EN |
Published: |
Georg Thieme Verlag KG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a579f2aee73f467a8bd1e62b2bbf4b46 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
by: Jana Úlehlová, et al.
Published: (2021) -
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
by: Caroline Sindet-Pedersen, et al.
Published: (2017) -
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
by: Frost C, et al.
Published: (2014) -
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
by: Frost C, et al.
Published: (2018) -
Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban
by: Anis TR, et al.
Published: (2021)